Dachman A F, Margolis H, Aboulafia E
Botsford General Hospital, Farmington Hills, Mich., USA.
J Am Osteopath Assoc. 1995 Feb;95(2):115-8, 121.
The authors report the first American case of a factor VIII inhibitor found in a patient with Sjögren's syndrome. The inhibitor was isolated from a patient with no known hematologic disorder who was seen with a compartment syndrome of the left thigh after sustaining a fall from bed. The Sjögren's syndrome had been previously diagnosed via lower lip biopsy. After fasciotomy, signs and symptoms of intra-abdominal hemorrhage developed, and the patient was taken to laparotomy, where no hemorrhage was found. A coagulopathy developed, and the patient's hemoglobin continued to fall. A complete factor analysis revealed a factor VIII inhibitor that was quantified at 40 Bethesda units. After vigorous therapy--which included factor concentrates, immunoglobulins, steroids, antifibrinolytic agents, and blood replacement--the patient's bleeding stopped and she continued to convalesce under hospital care until her ultimate death from respiratory problems. Acquired hemophilia with a factor VIII inhibitor may be associated with Sjögren's syndrome.
作者报告了美国首例在干燥综合征患者中发现的凝血因子VIII抑制物病例。该抑制物来自一名无已知血液系统疾病的患者,其因从床上跌落导致左大腿骨筋膜室综合征前来就诊。干燥综合征此前已通过下唇活检确诊。筋膜切开术后,患者出现腹腔内出血的症状和体征,遂接受剖腹探查,但未发现出血情况。患者出现了凝血病,血红蛋白持续下降。全面的因子分析显示存在凝血因子VIII抑制物,其定量为40贝塞斯达单位。经过积极治疗,包括使用凝血因子浓缩物、免疫球蛋白、类固醇、抗纤溶药物和输血,患者的出血停止,在医院护理下继续康复,直至最终因呼吸问题死亡。获得性血友病伴凝血因子VIII抑制物可能与干燥综合征有关。